Project Name：Vildagliptin 

Registration Classification：3+6

Formulations and specifications ：Tablets: 50mg 

Indications：This product is suitable for the treatment of type 2 diabetes : When  metformin is already being used to the maximum tolerated dose  as monotherapy still can not effectively control blood sugar, this product can be used in combination with metformin .

Original Research Company：Novartis Pharma Stein AG

Progress ：Pharmaceutical Research in progress